Clinical trial
Neuroinflammation in Frontotemporal Lobar Degeneration - a Multimodal Biomarker Study
NCT06870838 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuroinflammation in Frontotemporal Lobar Degeneration - a Multimodal Biomarker Study
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 25, 2023
- Completion date
- August 31, 2026
- Enrollment
- 110 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
behavioral variant frontotemporal dementia (bvftd), corticobasal syndrome(cbs), frontotemporal lobar degeneration (ftld), primary progressive aphasia(ppa), progressive supranuclear palsy(psp)